Intermittent fasting improves hepatic end points in nonalcoholic fatty liver disease: A systematic review and meta-analysis
Background and Aims:. Despite NAFLD being the most prevalent liver disease globally, currently there are no FDA-approved treatments, and weight loss through caloric restriction and enhanced physical activity is the recommended treatment strategy. Intermittent fasting (IF) has been proposed as an alt...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Health/LWW
2023-08-01
|
| Colecção: | Hepatology Communications |
| Acesso em linha: | http://journals.lww.com/10.1097/HC9.0000000000000212 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|